A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.

Previously-proposed rheumatoid arthritis (RA) HLA-DRB1 susceptibility and protective models were compared, based on amino acids at positions 67-74 and autoantibody combinations. 3 657 RA patients and 1 357 controls were studied using logistic regression, with secondary stratification by anti-citrull...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Mackie, S, Taylor, J, Martin, S, Wordsworth, P, Steer, S, Wilson, A, Worthington, J, Emery, P, Barrett, J, Morgan, A
التنسيق: Journal article
اللغة:English
منشور في: 2012
_version_ 1826274277068898304
author Mackie, S
Taylor, J
Martin, S
Wordsworth, P
Steer, S
Wilson, A
Worthington, J
Emery, P
Barrett, J
Morgan, A
author_facet Mackie, S
Taylor, J
Martin, S
Wordsworth, P
Steer, S
Wilson, A
Worthington, J
Emery, P
Barrett, J
Morgan, A
author_sort Mackie, S
collection OXFORD
description Previously-proposed rheumatoid arthritis (RA) HLA-DRB1 susceptibility and protective models were compared, based on amino acids at positions 67-74 and autoantibody combinations. 3 657 RA patients and 1 357 controls were studied using logistic regression, with secondary stratification by anti-citrullinated peptide antibodies(ACPA) and rheumatoid factor(RF). Susceptibility models were based on previously defined HLA-DRB1 shared epitope(SE) subgroups. (70)DERAA(74), D(70) and I(67) protective models were compared, adjusting for HLA-DRB1 SE. A hierarchy of risk was observed within the HLA-DRB1 SE, particularly for ACPA-positive and RF-positive RA: HLA-DRB1(*)0401∼(*)0404>(*)0101∼(*)1001 ((*)0404>(*)0101: P=0.0003). HLA-DRB1(*)0401/(*)0404 compound heterozygosity conferred a risk similar to (*)0401 homozygosity (P=0.70). Protective effects of D(70) and I(67) were similar. Predictions of the D(70) model fitted the data better than those of the I(67) model. The protective effect of D(70) showed a gene-dose effect (OR 0.82, 95% CI 0.73-0.92, P=5.8 × 10(-4)), but was only seen in RA patients positive for RF or ACPA. HLA-DRB1 SE alleles were also associated with ACPA-negative, RF-positive RA (OR 1.42 (1.15-1.76), P=0.0012). In conclusion, HLA-DRB1 SE alleles show heterogeneity in RA susceptibility; their major effect appears to be mediated by ACPA positivity, but a significant association of HLA-DRB1 SE with RF-positive, ACPA-negative RA was also observed. D(70) specifically protected against antibody-positive RA.
first_indexed 2024-03-06T22:41:00Z
format Journal article
id oxford-uuid:5b8d0d8c-a1e3-46c3-ad1a-61debd0ba82b
institution University of Oxford
language English
last_indexed 2024-03-06T22:41:00Z
publishDate 2012
record_format dspace
spelling oxford-uuid:5b8d0d8c-a1e3-46c3-ad1a-61debd0ba82b2022-03-26T17:22:48ZA spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5b8d0d8c-a1e3-46c3-ad1a-61debd0ba82bEnglishSymplectic Elements at Oxford2012Mackie, STaylor, JMartin, SWordsworth, PSteer, SWilson, AWorthington, JEmery, PBarrett, JMorgan, APreviously-proposed rheumatoid arthritis (RA) HLA-DRB1 susceptibility and protective models were compared, based on amino acids at positions 67-74 and autoantibody combinations. 3 657 RA patients and 1 357 controls were studied using logistic regression, with secondary stratification by anti-citrullinated peptide antibodies(ACPA) and rheumatoid factor(RF). Susceptibility models were based on previously defined HLA-DRB1 shared epitope(SE) subgroups. (70)DERAA(74), D(70) and I(67) protective models were compared, adjusting for HLA-DRB1 SE. A hierarchy of risk was observed within the HLA-DRB1 SE, particularly for ACPA-positive and RF-positive RA: HLA-DRB1(*)0401∼(*)0404>(*)0101∼(*)1001 ((*)0404>(*)0101: P=0.0003). HLA-DRB1(*)0401/(*)0404 compound heterozygosity conferred a risk similar to (*)0401 homozygosity (P=0.70). Protective effects of D(70) and I(67) were similar. Predictions of the D(70) model fitted the data better than those of the I(67) model. The protective effect of D(70) showed a gene-dose effect (OR 0.82, 95% CI 0.73-0.92, P=5.8 × 10(-4)), but was only seen in RA patients positive for RF or ACPA. HLA-DRB1 SE alleles were also associated with ACPA-negative, RF-positive RA (OR 1.42 (1.15-1.76), P=0.0012). In conclusion, HLA-DRB1 SE alleles show heterogeneity in RA susceptibility; their major effect appears to be mediated by ACPA positivity, but a significant association of HLA-DRB1 SE with RF-positive, ACPA-negative RA was also observed. D(70) specifically protected against antibody-positive RA.
spellingShingle Mackie, S
Taylor, J
Martin, S
Wordsworth, P
Steer, S
Wilson, A
Worthington, J
Emery, P
Barrett, J
Morgan, A
A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.
title A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.
title_full A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.
title_fullStr A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.
title_full_unstemmed A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.
title_short A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.
title_sort spectrum of susceptibility to rheumatoid arthritis within hla drb1 stratification by autoantibody status in a large uk population
work_keys_str_mv AT mackies aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT taylorj aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT martins aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT wordsworthp aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT steers aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT wilsona aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT worthingtonj aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT emeryp aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT barrettj aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT morgana aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT mackies spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT taylorj spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT martins spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT wordsworthp spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT steers spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT wilsona spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT worthingtonj spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT emeryp spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT barrettj spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation
AT morgana spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation